Author

Ramla Kosozi

Institution: Vanderbilt University

Observed institution: Vanderbilt University

OpenAlex ID: A5089680363

Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma

2018 · Harry Yoon, Lilit Karapetyan, et al. · The Oncologist · 9

Works count: 1

Citation count: 9

H-index: 1

I10-index: